SABER
Live / Registered — Registered (as of 09 Jan 2024)
What this means for you
Registered since 09 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97348769
- Registration number
- 7265836
- Mark type
- Stylized text
- Filed
- 06 Apr 2022
- Published for opposition
- 24 Oct 2023
- Registered
- 09 Jan 2024
- Attorney of record
- Lynn E. Rzonca
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable computer software for the analysis of microfluidic assays, biological assays, Tcell based assays, antigen detection assays, cell based assays, antibody assays; Microfluidic instruments, namely, chips, cartridges, droplet makers, droplet analyzers, droplet sorters, droplet imagers, droplet readers, droplet manipulators for performing microfluidics based assays, particularly biological assays, T-cell based assays, antigen detection assays, cell based assays, antibody assays, cell-cell assays, immune response assays, assays using immune cells, using blood, tumor cells, cell suspension, mammalian cell, eukaryote and procaryotes cells assays, synthetic biology assays; scientific apparatus and instruments for analyzing eukaryote and procaryotes cells, not for medical purposes, in the nature of chips, cartridges, droplet makers, droplet analyzers, droplet sorters, droplet imagers, droplet readers, droplet manipulators; scientific apparatus and instruments for analyzing single cells, not for medical purposes, in the nature of chips, cartridges, droplet makers, droplet analyzers, droplet sorters, droplet imagers, droplet readers, droplet manipulators; scientific apparatus and instruments for analyzing cells using optical components, not for medical purposes, in the nature of chips, cartridges, droplet makers, droplet analyzers, droplet sorters, droplet imagers, droplet readers, droplet manipulators; none of the foregoing relating to percutaneous transluminal angioplasty and/or catheters
- Class 010 — Medical apparatus: Medical instruments for the purpose of detecting cancer, immune response, infectious diseases, metabolic diseases; medical devices for viewing genomes for analysis in the fields epigenomics, transcriptomics, proteomics; Cell culture apparatus for medical use, namely, cell culture reservoirs or containers; Medical apparatuses for analyzing, manipulating, or altering cells in particular human cells; none of the foregoing relating to percutaneous transluminal angioplasty and/or catheters
- Class 042 — Scientific and technological services: Research and development in the field of microorganisms and cells; scientific research services relating to the isolation and cultivation of human tissues and cells; research in the field of cell separation technology; scientific research services in the field of cell separation; Biological research; Clinical research in the field of oncology, biotechnology, epidemiology, immune-oncology, infectious disease epidemiology, metabolic disease, microbiology, immunology, genomics, epigenomics, transcriptomics; Biotechnological research; Medical research; Biological research; Bacteriological research; Medical research services; Biological research services; scientific testing in the field of biotechnology; Scientific research in the field of genetics and genetic engineering; none of the foregoing relating to percutaneous transluminal angioplasty and/or catheters; none of the foregoing in the field of agriculture and farming
Owner
- Saber Bio SAS, Paris, FR
- Saber Bio SAS, Paris, FR
- Saber Bio SAS, Paris, FR
Prosecution history
- 09 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Oct 2023 — PUBLISHED FOR OPPOSITION
- 04 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Sept 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 15 Sept 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 08 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Aug 2023 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 13 Jun 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 13 Jun 2023 — FINAL REFUSAL E-MAILED
- 13 Jun 2023 — FINAL REFUSAL WRITTEN
- 05 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED